CA2621436A1 - Methode de regulation de vitesses de sedimentation - Google Patents
Methode de regulation de vitesses de sedimentation Download PDFInfo
- Publication number
- CA2621436A1 CA2621436A1 CA002621436A CA2621436A CA2621436A1 CA 2621436 A1 CA2621436 A1 CA 2621436A1 CA 002621436 A CA002621436 A CA 002621436A CA 2621436 A CA2621436 A CA 2621436A CA 2621436 A1 CA2621436 A1 CA 2621436A1
- Authority
- CA
- Canada
- Prior art keywords
- acd
- cells
- blood
- mls
- bone marrow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004062 sedimentation Methods 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims description 15
- 239000012530 fluid Substances 0.000 claims abstract description 30
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 15
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 15
- 210000004369 blood Anatomy 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 23
- 210000001185 bone marrow Anatomy 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 12
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- 238000005194 fractionation Methods 0.000 claims description 3
- 230000010100 anticoagulation Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 description 25
- 210000003743 erythrocyte Anatomy 0.000 description 13
- 239000000306 component Substances 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 8
- 210000004623 platelet-rich plasma Anatomy 0.000 description 7
- 210000001772 blood platelet Anatomy 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Landscapes
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90166007P | 2007-02-16 | 2007-02-16 | |
US60/901,660 | 2007-02-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2621436A1 true CA2621436A1 (fr) | 2008-08-16 |
Family
ID=39651227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002621436A Abandoned CA2621436A1 (fr) | 2007-02-16 | 2008-02-15 | Methode de regulation de vitesses de sedimentation |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080213743A1 (fr) |
EP (1) | EP1972380A1 (fr) |
JP (1) | JP2008231095A (fr) |
CN (1) | CN101513544A (fr) |
AU (1) | AU2008200733A1 (fr) |
CA (1) | CA2621436A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8984932B2 (en) | 2012-07-18 | 2015-03-24 | Theranos, Inc. | Rapid measurement of formed blood component sedimentation rate from small sample volumes |
WO2014015177A1 (fr) | 2012-07-18 | 2014-01-23 | Theranos, Inc. | Mesure rapide du taux de sédimentation des éléments figurés du sang dans des échantillons de petit volume |
CN113588501A (zh) * | 2015-12-08 | 2021-11-02 | 生物马特里卡公司 | 降低红细胞沉降速率 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614106A (en) * | 1993-03-12 | 1997-03-25 | Baxter International Inc. | Method and apparatus for collection of platelets |
EP1000664B1 (fr) * | 1995-04-18 | 2005-06-15 | Gambro, Inc., | Appareil et procédé de séparation de particules |
WO2000061256A1 (fr) | 1999-04-12 | 2000-10-19 | Harvest Technologies Corporation | Methode et appareil permettant de produire un plasma riche en plaquettes et/ou un concentre de plaquettes |
US8980568B2 (en) * | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
US7291450B2 (en) * | 2003-03-28 | 2007-11-06 | Smith & Nephew, Inc. | Preparation of a cell concentrate from a physiological solution |
-
2008
- 2008-02-15 JP JP2008034238A patent/JP2008231095A/ja not_active Abandoned
- 2008-02-15 CA CA002621436A patent/CA2621436A1/fr not_active Abandoned
- 2008-02-15 EP EP08002831A patent/EP1972380A1/fr not_active Withdrawn
- 2008-02-15 AU AU2008200733A patent/AU2008200733A1/en not_active Abandoned
- 2008-02-18 CN CNA2008100807621A patent/CN101513544A/zh active Pending
- 2008-02-19 US US12/071,234 patent/US20080213743A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101513544A (zh) | 2009-08-26 |
AU2008200733A1 (en) | 2008-09-04 |
US20080213743A1 (en) | 2008-09-04 |
EP1972380A1 (fr) | 2008-09-24 |
JP2008231095A (ja) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12011463B2 (en) | Multilayered blood product | |
Efeoglu et al. | A modified method for preparing platelet-rich plasma: an experimental study | |
AU2012202594B2 (en) | Thrombin isolated from blood and blood fractions | |
US20080213743A1 (en) | Method for adjusting sedimentation rates | |
JP5860736B2 (ja) | 血小板機能を決定するための装置及び方法 | |
Bartels et al. | Intraoperative autotransfusion in aortic surgery: Comparison of whole blood autotransfusion versus cell separation | |
Reinhart et al. | The passage of a hemodialysis filter affects hemorheology, red cell shape, and platelet aggregation | |
US20020084221A1 (en) | Method for precipitating red blood cells | |
Feuring, A. Gutfleisch, A. Ganschow, E. Richter, H. Eichler, CE Dempfle, HC Tillmann, A. Schultz, M. Wehling | Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100™ | |
Järemo et al. | Some storage characteristics of buffy coats used for preparation of platelet concentrates | |
Robert C et al. | In vitro analysis of shed blood from patients undergoing total knee replacement surgery | |
TWI775179B (zh) | 高濃度血小板血漿分離套組及使用其之方法 | |
Acton | Advances in Blood Research and Application: 2013 Edition | |
JP2005006821A (ja) | 血液を血漿層/血球層に分離するための採血器具および方法 | |
US20220118441A1 (en) | Kit for isolation of platelet-rich plasma and the method using the same | |
Muthu et al. | Standardization and Validation of a High Yield Conventional Platelet-rich Plasma Preparation Protocol | |
WO2023069027A1 (fr) | Tube destiné à un procédé avancé d'obtention de fibrine riche en plaquettes | |
Serrick et al. | Partial bowls using the Haemonetics Cell Saver 5: does it produce a quality product? | |
Baerlocher et al. | Gel‐filtration of sickle erythrocytes: Separation based on cell deformability | |
Latza et al. | Platelet function in platelet concentrates during storage: Comparison of two blood cell separators | |
Persson et al. | A filtrometric study on red blood cells after storage in frozen form | |
JP2014117347A (ja) | 血清の調製方法及び血清 | |
JPH11192216A (ja) | 血液成分採取用容器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |